WO2013003465A9 - Methods and compositions for treating skin - Google Patents

Methods and compositions for treating skin Download PDF

Info

Publication number
WO2013003465A9
WO2013003465A9 PCT/US2012/044407 US2012044407W WO2013003465A9 WO 2013003465 A9 WO2013003465 A9 WO 2013003465A9 US 2012044407 W US2012044407 W US 2012044407W WO 2013003465 A9 WO2013003465 A9 WO 2013003465A9
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
treating skin
skin
treating
Prior art date
Application number
PCT/US2012/044407
Other languages
French (fr)
Other versions
WO2013003465A2 (en
Inventor
Belinda Tsao Nivaggioli
Original Assignee
Avicena Group, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avicena Group, Inc. filed Critical Avicena Group, Inc.
Publication of WO2013003465A2 publication Critical patent/WO2013003465A2/en
Publication of WO2013003465A9 publication Critical patent/WO2013003465A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
PCT/US2012/044407 2011-06-28 2012-06-27 Methods and compositions for treating skin WO2013003465A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161502058P 2011-06-28 2011-06-28
US61/502,058 2011-06-28

Publications (2)

Publication Number Publication Date
WO2013003465A2 WO2013003465A2 (en) 2013-01-03
WO2013003465A9 true WO2013003465A9 (en) 2013-03-28

Family

ID=47424783

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/044407 WO2013003465A2 (en) 2011-06-28 2012-06-27 Methods and compositions for treating skin

Country Status (1)

Country Link
WO (1) WO2013003465A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3775285B1 (en) * 2018-06-15 2021-10-06 Unilever IP Holdings B.V. Epigenetic method to assess sun exposure
CN111035583A (en) * 2019-12-23 2020-04-21 广州市拉凯尔干细胞研究所 Skin care product composition for improving true epidermis junction layer

Also Published As

Publication number Publication date
WO2013003465A2 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
IL260585B (en) Compositions and methods for treating retinal diseases
HK1201475A1 (en) Methods and compositions for treating pain
EP2684167A4 (en) Compositions and methods useful for treating diseases
EP2655334A4 (en) Compositions and methods useful for treating diseases
IL227429A0 (en) Compositions and methods for treating cancer
EP2755482A4 (en) Compositions and methods for treating cancer
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
EP2544655A4 (en) Compositions and methods for treating skin
EP2688594A4 (en) Methods and compositions for the treatment of cancer
EP2771341A4 (en) Novel compositions and methods for treating cancer
EP2766009A4 (en) Method and compositions for treating skin
WO2012054862A9 (en) Agents, compositions, and methods for treating pruritis and related skin conditions
DK3292875T3 (en) Compositions and methods for treating diseases
EP2830654B8 (en) Methods and compositions for treating inflammation
KR20180085062A (en) Composition and method for treating skin conditions
IL229231A0 (en) Compositions and methods for treating cancer
GB2509033B (en) Composition for coloring skin and method for coloring skin
WO2013003465A9 (en) Methods and compositions for treating skin
EP2714082A4 (en) Compositions and methods for treating pain
EP2695604A4 (en) Spirulina-containing cosmetic composition and cosmetic treatment method
ZA201308683B (en) Methods and compositions suitable for preventing and treating hyperleptinemia
AU2011903969A0 (en) Compositions for treating skin conditions
AU2011901980A0 (en) Composition and treatment for water
AU2011902301A0 (en) Novel Formulation and Treatment Methods
WO2013006854A9 (en) Compositions and methods for treating enterobacteriaceae

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12803829

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 21-05-2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12803829

Country of ref document: EP

Kind code of ref document: A2